Valeo Financial Advisors’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,800
Closed -$46K 1922
2021
Q1
$46K Buy
+1,800
New +$45.1K ﹤0.01% 908

Other funds holding RNLX

Valeo Financial Advisors's RNLX Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Renalytix plc American Depositary Shares (RNLX) in Q2 2021, closing a stake of 1,800 shares — an estimated $46K sold.

Valeo Financial Advisors first reported a position in RNLX in Q1 2021 and held it in 1 quarter. The position peaked at $46K in Q1 2021. 41 funds tracked by Wall St. Rank hold RNLX as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Renalytix plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 1,800 Renalytix plc American Depositary Shares shares in Q2 2021, an estimated $46K.
  • Valeo Financial Advisors first reported a position in Renalytix plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Valeo Financial Advisors's Renalytix plc American Depositary Shares position peaked at $46K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.